XenoPort to Release Second Quarter Financial Results on August 6, 2014
July 22 2014 - 12:00PM
Business Wire
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will
release its second quarter financial results on August 6, 2014 at
approximately 4:30 p.m. Eastern Time. The company will host a
conference call at 5:00 p.m. Eastern Time that same day. A replay
of the call will be available for one week following the event.
To access the conference call via the Internet, go to
www.XenoPort.com. Please join the call at least 15 minutes prior to
the start to ensure time for any software downloads that may be
required.
To access the live conference call via phone, dial
1-888-275-3514. International callers may access the live call by
dialing 706-679-1417. The reference number to enter the call is
72884596.
The replay of the conference call may be accessed that same day
after 8:00 p.m. Eastern Time, via the Internet, at
www.XenoPort.com, or via phone at 1-855-859-2056 for domestic
callers, or 404-537-3406 for international callers. The reference
number to enter the replay of the call is 72884596.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on
developing and commercializing a portfolio of internally discovered
product candidates for the potential treatment of neurological
disorders. XenoPort is currently commercializing HORIZANT®
(gabapentin enacarbil) Extended-Release Tablets in the United
States and developing its novel fumaric acid ester product
candidate, XP23829, as a potential treatment for moderate-to-severe
chronic plaque type psoriasis and/or relapsing forms of multiple
sclerosis. REGNITE® (gabapentin enacarbil) Extended-Release Tablets
is being marketed in Japan by Astellas Pharma Inc. XenoPort
recently granted exclusive world-wide rights for the development
and commercialization of its clinical-stage oral product candidate,
arbaclofen placarbil, to Reckitt Benckiser Pharmaceuticals, Inc.
for all indications. To learn more about XenoPort, please visit the
website at www.XenoPort.com.
XENOPORT, HORIZANT and REGNITE are registered trademarks of
XenoPort, Inc.
XNPT2F
XenoPort, Inc.Jackie Cossmon, 408-616-7295ir@XenoPort.com
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Sep 2023 to Sep 2024